Gene · 23521
NIH grants2,185
NIH grants whose papers are about the gene, through NIH's grant-paper links.
621 to 640 of 2,185
Download this page as JSON| Grant | Title | RPL13A papers | Newest fiscal year |
|---|---|---|---|
| U01HL134655 | Transplantation of MHC Homozygous Vascular Progenitors in Primates | 4 | 2022 |
| DP2EB025760 | Using Cell Priming and Telecommunications Modeling to Enhance Gene Delivery for Stem Cell Therapies | 3 | 2022 |
| K01OD023219 | Mechanisms of Interferon Regulatory Factor Dysfunction by Cutaneous Papillomaviruses | 3 | 2022 |
| P30DK079310 | George M. O'Brien Kidney Center at Yale | 3 | 2022 |
| K24AI135034 | Mentoring Patient Oriented Research in Allergic Eosinophilic Gastrointestinal Disorders | 2 | 2022 |
| R00HG009917 | Systematic mapping and prediction of gene-enhancer connections | 2 | 2022 |
| R01AI138960 | Signals that establish and maintain HIV latency | 2 | 2022 |
| R01CA214948 | Targeting Metabolic Liabilities in Cancer | 2 | 2022 |
| R01DK124203 | Assay Development for Discovery of a Small Molecule Inhibitor of a Novel Metabolic Pathway that Drives Obesity | 2 | 2022 |
| R25GM060507 | LLU-NIH Initiative for Maximizing Student Development | 2 | 2022 |
| R43CA271996 | Preventing in vivo resistance to PI3K/AKT/mTOR inhibitors through Mediator kinase inhibition | 2 | 2022 |
| T32GM007544 | Michigan Predoctoral Training in Genetics | 2 | 2022 |
| T32GM008490 | Predoctoral Training Program in Genetics | 2 | 2022 |
| F30CA236436 | Function of IRF8 in T cell activation and immune tolerance | 1 | 2022 |
| F30CA239335 | Defining the stromal landscape that sustains AML drug resistance | 1 | 2022 |
| F31NS115290 | Brain estrogen as a regulator of post-menopausal VCID | 1 | 2022 |
| F32GM137463 | Molecular mechanisms of the ACF chromatin remodeling complex | 1 | 2022 |
| I01BX001228 | Autoinflammation in Human Melanoma | 1 | 2022 |
| K99CA255936 | Mechanisms of translational output control in pancreatic cancer | 1 | 2022 |
| KL2TR002492 | Institutional Career Development Core | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/grants?page=32